Novo Nordisk Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Biologic Drugs for Novo Nordisk Inc
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 1991-06-25 | See Plans and Pricing | |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 1991-06-25 | 5,462,535 | See Plans and Pricing |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 1991-06-25 | 5,626,566 | See Plans and Pricing |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 1991-06-25 | 5,693,027 | See Plans and Pricing |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 1991-06-25 | 5,980,491 | See Plans and Pricing |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 1991-06-25 | 6,126,646 | See Plans and Pricing |
Novo Nordisk Inc. | NOVOLIN N | insulin isophane human | Injectable Suspension | 019959 | 1991-07-01 | See Plans and Pricing | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
This search can help find similar names.